200 related articles for article (PubMed ID: 12076296)
1. Use of enzyme treatment to enhance reactivity of HLA and platelet-specific antibodies in solid-phase RBC adherence assays.
Leach MF; AuBuchon JP
Transfusion; 2002 Apr; 42(4):476-80. PubMed ID: 12076296
[TBL] [Abstract][Full Text] [Related]
2. Screening for platelet antibodies in adult idiopathic thrombocytopenic purpura: a comparative study using solid phase red cell adherence assay and flow cytometry.
Lin JS; Lyou JY; Chen YJ; Chen PS; Liu HM; Ho CH; Hao TC; Tzeng CH
J Chin Med Assoc; 2006 Dec; 69(12):569-74. PubMed ID: 17182350
[TBL] [Abstract][Full Text] [Related]
3. Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.
Vongchan P; Nawarawong W; Linhardt RJ
Am J Clin Pathol; 2008 Sep; 130(3):455-66. PubMed ID: 18701420
[TBL] [Abstract][Full Text] [Related]
4. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a solid phase red cell adherence technique for platelet antibody screening.
Lown JA; Ivey JG
Transfus Med; 1991 Sep; 1(3):163-7. PubMed ID: 9259843
[TBL] [Abstract][Full Text] [Related]
6. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions.
Lo SC; Lin DT; Lin SW; Chang JS
J Formos Med Assoc; 2000 Dec; 99(12):902-5. PubMed ID: 11155742
[TBL] [Abstract][Full Text] [Related]
7. [Establish a Graded Method to Avoid HLA Class I Antibodies Corresponding Antigen and Combining HLAMatchmaker Application in Improving the CCI Value after Platelet Transfusion for Patients with IPTR].
Gao SQ; Xu YP; Luo CR; Li DC; Pen L; Liu T; Zou QC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):242-249. PubMed ID: 38387929
[TBL] [Abstract][Full Text] [Related]
8. Enzyme treatment of platelets for antibody detection.
Lown J
Transfusion; 2003 Jun; 43(6):835; author reply 835. PubMed ID: 12757545
[No Abstract] [Full Text] [Related]
9. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients.
Buakaew J; Promwong C
Asian Pac J Allergy Immunol; 2010; 28(2-3):177-84. PubMed ID: 21038788
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
11. Comparison of solid-phase red cell adherence and microcolumn agglutination technology using untreated and enzyme-treated red blood cells.
Sanders DR
Immunohematology; 2023 Dec; 39(4):166-171. PubMed ID: 38179782
[TBL] [Abstract][Full Text] [Related]
12. Red cells, HLA and platelet antibody formation in patients with multiple transfusions.
Chow MP; Hu HY; Lyou JY; Lin JS; Yung CH; Lee A; Lee TD
Acta Haematol; 1994; 92(2):57-60. PubMed ID: 7817704
[TBL] [Abstract][Full Text] [Related]
13. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
Brubaker DB; Romine M
Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
[TBL] [Abstract][Full Text] [Related]
14. Application of lyophilised human platelets for antibody detection in solid phase red cell adherence assay.
Duan S; Wang M; Ding S; Chen Y; Wei S; Chen W; Zhang C; Li Y; Wang H
J Immunol Methods; 2020 Dec; 487():112868. PubMed ID: 32941887
[TBL] [Abstract][Full Text] [Related]
15. Platelet antibody detection in pediatric immune thrombocytopenic purpura: evaluation of three screening methods.
Biglino P; Perutelli P; Mori PG
Vox Sang; 1997; 72(4):242-6. PubMed ID: 9228716
[TBL] [Abstract][Full Text] [Related]
16. Pan-reactive platelet antibodies in post-transfusion purpura.
Taaning E; Tønnesen F
Vox Sang; 1999; 76(2):120-3. PubMed ID: 10085529
[TBL] [Abstract][Full Text] [Related]
17. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
[TBL] [Abstract][Full Text] [Related]
18. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
[TBL] [Abstract][Full Text] [Related]
19. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
20. A serum factor which inhibits serologic reactions with enzyme-treated red blood cells.
Lown JA; Holland PA; Barr AL
Transfusion; 1982; 22(2):143-6. PubMed ID: 6803408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
